BVS
Bioventus Inc.
NASDAQ · Healthcare · Medical - Devices · US
$13.26
−3.95%Price chart
Sep 17Sep 22Sep 25Sep 30Oct 5Oct 8Oct 13Oct 16
Key dataOct 16, 2026
Open$14.09
From 52W high−13.07%
Volume111058.00
Market cap$906.06M
P/E (TTM)16.5x
P/S (TTM)1.6x
Div yield—
Key dataOct 16, 2026
Open
$14.09
From 52W high
−13.07%
Volume
111058.00
Market cap
$906.06M
ValuationView details →
P/E (Fwd)
15.7x
EV/EBITDA
11.5x
P/E (TTM)
16.5x
RSI (14)
50.9
MomentumView details →
1D Return
−3.95%
YTD Return
+81.22%
SummaryUpdated Jun 1, 2026
Bioventus Inc. (NASDAQ:BVS) is a medical device company founded in 2011 and headquartered in Durham, North Carolina. The company went public in February 2021 and focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing processes. Bioventus serves physicians across the orthopedic continuum in various settings including physician offices, ambulatory surgical centers, and hospitals. The company has experienced significant operational challenges in recent years but has been working to stabilize its business and return to profitable growth through strategic divestitures and operational improvements.
Similar companies
Latest newsMore news →